1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Topics

Showing 1,267 results.

$Thumbnail for Treatment Preferences and Perceived Barriers to Epcoritamab Plus Rituximab and Lenalidomide in Relapsed/Refractory Follicular Lymphoma: A Real-World Survey of US Hematologists/Oncologists$

IBCL - 236

Treatment Preferences and Perceived Barriers to Epcoritamab Plus Rituximab and Lenalidomide in Relapsed/Refractory Follicular Lymphoma: A Real-World Survey of US Hematologists/Oncologists

Blaise Nwotchouang

Poster Presenter: Blaise Nwotchouang

Thumbnail for Light Chain Amyloidosis in Waldenstrφm Macroglobulinemia/Lymphoplasmacytic Lymphoma: Treatment Strategies and Outcomes of 74 Cases

IBCL - 290

Light Chain Amyloidosis in Waldenstrφm Macroglobulinemia/Lymphoplasmacytic Lymphoma: Treatment Strategies and Outcomes of 74 Cases

Nicol? Danesin

Poster Presenter: Nicol? Danesin

SOHO 2026 Annual Meeting

Topics

Treatment Preferences and Perceived Barriers to Epcoritamab Plus Rituximab and Lenalidomide in Relapsed/Refractory Follicular Lymphoma: A Real-World Survey of US Hematologists/Oncologists

Light Chain Amyloidosis in Waldenstrφm Macroglobulinemia/Lymphoplasmacytic Lymphoma: Treatment Strategies and Outcomes of 74 Cases

Patterns of Treatment Utilization and Sequencing Across Lines of Therapy in Waldenstrφm Macroglobulinemia: Real-World Evidence From the United States

CD10 Loss Defines a Biologically Distinct and Extranodal-Enriched Subset of Follicular Lymphoma: A Systematic Review and Meta-Analysis

Relapse-Mortality Trade-off Between Autologous and Allogeneic Stem Cell Transplantation in Relapsed Follicular lymphoma and Marginal zone lymphoma: A Registry-Based Proportional Meta-Analysis

Fixed Duration Subcutaneous Mosunetuzumab had Better Practice Efficiency versus Treat-To-Progression Subcutaneous Epcoritamab in Third-Line or Later Follicular Lymphoma: An Economic Analysis

Beyond Hemolysis: Etiologic Diversity and Diagnostic Challenges in Cold Agglutinin Disorders With Implications for Targeted Therapy

Diagnostic Delays and Comparable Response Rates to iMCD-Directed Therapies in Patients With and Without Expert-Confirmed Idiopathic Multicentric Castleman Disease Diagnoses

Clinical Characteristics and Survival Outcomes in Waldenstrφm Macroglobulinemia: An Updated Analysis of 10574 Patients From the SEER Database (1975-2020)